| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Air pollution and lung cancer survival in Pennsylvania
|
McKeon, Thomas P.
|
|
|
170 |
C |
p. 65-73
|
artikel
|
| 2 |
Assessment of treatment strategies for stage I non-small cell lung cancer in patients with comorbidities
|
Sigel, Keith
|
|
|
170 |
C |
p. 34-40
|
artikel
|
| 3 |
Clinicopathologic and genomic features of high-grade pattern and their subclasses in lung adenocarcinoma
|
Ahn, Bokyung
|
|
|
170 |
C |
p. 176-184
|
artikel
|
| 4 |
Contents
|
|
|
|
170 |
C |
p. v-vi
|
artikel
|
| 5 |
Correlations between objective response rate and survival-based endpoints in first-line advanced non-small cell lung Cancer: A systematic review and meta-analysis
|
Goring, Sarah
|
|
|
170 |
C |
p. 122-132
|
artikel
|
| 6 |
Cost-effectiveness analyses of durvalumab consolidation therapy versus no consolidation therapy after chemoradiotherapy in stage-III NSCLC
|
Hussain, Salman
|
|
|
170 |
C |
p. 11-19
|
artikel
|
| 7 |
Decoding circulating tumor DNA to identify durable benefit from immunotherapy in lung cancer
|
Donker, Hylke C.
|
|
|
170 |
C |
p. 52-57
|
artikel
|
| 8 |
Detection of non-metastatic non-small-cell lung cancer in urine by methylation-specific PCR analysis: A feasibility study
|
Wever, B.M.M.
|
|
|
170 |
C |
p. 156-164
|
artikel
|
| 9 |
Development and validation of a blood-based genomic mutation signature to predict the clinical outcomes of atezolizumab therapy in NSCLC
|
Liu, Manjiao
|
|
|
170 |
C |
p. 148-155
|
artikel
|
| 10 |
DNA methylation-based machine learning classification distinguishes pleural mesothelioma from chronic pleuritis, pleural carcinosis, and pleomorphic lung carcinomas
|
Jurmeister, Philipp
|
|
|
170 |
C |
p. 105-113
|
artikel
|
| 11 |
Dosimetric predictors of pneumonitis in locally advanced non-small cell lung cancer patients treated with chemoradiation followed by durvalumab
|
Gao, Robert W.
|
|
|
170 |
C |
p. 58-64
|
artikel
|
| 12 |
Editorial Board
|
|
|
|
170 |
C |
p. iii
|
artikel
|
| 13 |
Effect of smoking habits on the efficacy of EGFR-TKI plus anti-angiogenic agent in advanced EGFR-mutant NSCLC
|
Qin, Bao-Dong
|
|
|
170 |
C |
p. 91-97
|
artikel
|
| 14 |
External validation of the eighth edition of the TNM classification for lung cancer in small cell lung cancer
|
Tan, Fengwei
|
|
|
170 |
C |
p. 98-104
|
artikel
|
| 15 |
High dose osimertinib in patients with advanced stage EGFR exon 20 mutation-positive NSCLC: Results from the phase 2 multicenter POSITION20 trial
|
Zwierenga, Fenneke
|
|
|
170 |
C |
p. 133-140
|
artikel
|
| 16 |
HLA-I diversity and tumor mutational burden by comprehensive next-generation sequencing as predictive biomarkers for the treatment of non-small cell lung cancer with PD-(L)1 inhibitors
|
Cuppens, Kristof
|
|
|
170 |
C |
p. 1-10
|
artikel
|
| 17 |
Practical considerations of single-fraction stereotactic ablative radiotherapy to the lung
|
Kang, Therese MJ.
|
|
|
170 |
C |
p. 185-193
|
artikel
|
| 18 |
Predicting checkpoint inhibitors pneumonitis in non-small cell lung cancer using a dynamic online hypertension nomogram
|
Jia, Xiaohui
|
|
|
170 |
C |
p. 74-84
|
artikel
|
| 19 |
Prognostic impact of artificial intelligence-based volumetric quantification of the solid part of the tumor in clinical stage 0-I adenocarcinoma
|
Kawaguchi, Yohei
|
|
|
170 |
C |
p. 85-90
|
artikel
|
| 20 |
Recurrence patterns and impact of brain metastases in synchronous single organ oligometastatic lung cancer following local ablative treatment – A multicenter analysis
|
Frost, Nikolaj
|
|
|
170 |
C |
p. 165-175
|
artikel
|
| 21 |
STK11 and KEAP1 mutations in non-small cell lung cancer patients: Descriptive analysis and prognostic value among Hispanics (STRIKE registry-CLICaP)
|
Cordeiro de Lima, Vladmir C.
|
|
|
170 |
C |
p. 114-121
|
artikel
|
| 22 |
Systematic review of the cost-effectiveness of screening for lung cancer with low dose computed tomography
|
Grover, Helen
|
|
|
170 |
C |
p. 20-33
|
artikel
|
| 23 |
The impact of station 4L lymph node dissection on short-term and long-term outcomes in non-small cell lung cancer
|
Wo, Yang
|
|
|
170 |
C |
p. 141-147
|
artikel
|
| 24 |
Treatment strategies and outcomes for patients with EGFR-mutant non-small cell lung cancer resistant to EGFR tyrosine kinase inhibitors: Focus on novel therapies
|
Johnson, Melissa
|
|
|
170 |
C |
p. 41-51
|
artikel
|
Tijdschrift beschrijving